Mr. Speaker, it has been estimated that one in ten Canadians suffer from a rare disorder, yet Canada is the only country in the developed world without an official definition for rare disorders or an orphan drug policy. This complicates patients accessing necessary medications and hinders needed medical and pharmaceutical research for these disorders.
My private member's motion M-426 addresses this problem. Why will the government not rectify the situation and respond to the needs of Canadians with rare disorders?